Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: A controlled, double-blind study

Archives of Internal Medicine

Volumn 159, Issue 15, 1999, Pages 1733-1740

  Cohen Mansfield, Jiska ^a,b   Lipson, Steven ^a   Werner, Perla ^a,c   Billig, Nathan ^b   Taylor, Levi ^a   Woosley, Raymond ^b  

^a Hebrew Home of Greater Washington   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF HAIFA   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; LORAZEPAM; THIORIDAZINE;

AGED; AGITATION; ANTICHOLINERGIC EFFECT; ARTICLE; BEHAVIOR DISORDER; BODY WEIGHT; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GERIATRIC CARE; HUMAN; MALE; MOOD; NURSING HOME; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RATING SCALE; SLEEP; SOMNOLENCE;

AFFECT; AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HOMES FOR THE AGED; HUMANS; LORAZEPAM; MALE; NURSING HOMES; SLEEP; SUBSTANCE WITHDRAWAL SYNDROME; SUBURBAN POPULATION; THIORIDAZINE;

EID: 0033598114     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.15.1733     Document Type: Article

References (31)

1. Beardsley RS, Larson DB, Burns BJ, Thompson JW, Kamerow DB. Prescribing of psychotropics in nursing home patients. J Am Geriatr Soc. 1989;37:327-330.
2. Buck JA. Psychotropic drug practice in nursing homes. J Am Geriatr Soc. 1988; 36:409-418.
3. Everitt DE, Fields DR, Soumerai SB, Avorn J. Resident behavior and staff distress in the nursing home. J Am Geriatr Soc. 1991;39:792-798.
4. Fitz D, Mallya A. Discontinuation of a psychogeriatric program for nursing home residents: psychotropic medication changes and behavioral reactions. J Appl Gerontol. 1992;11:50-63.
5. Avorn J, Soumerai SB, Everitt DE, et al. Randomized trial of a program to reduce the use of psychoactive drugs in the nursing home. N Engl J Med. 1992;327: 168-173.
6. Fitz D, Mallya A. Behavioral reactions to psychotropic medication changes for nursing home residents receiving psychogeriatric programming. J Appl Gerontol. 1990;9:194-210.
7. Rovner BW, Edelman BA, Cox MP, Shmuely Y. The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatr. 1992;149:1390-1392.
8. Thapa PB, Meador KG, Gideon P, Fought RL, Ray WA. Effects of antipsychotic withdrawal in elderly nursing home residents. J Am Geriatr Soc. 1994;42:280-286.
9. Hesse KA, Driscoll A, Jacobs S. Neuroleptic prescriptions for acutely ill geriatric patients. Arch Intern Med. 1993;153:2581-2587.
10. Auer SR, Monteiro I, Torossian C, Sinaiko E, Boksay I, Reisberg B. The treatment of behavioral symptoms in dementia: haloperidol, thioridazine, and fluoxetine: a double-blind, placebo-controlled, eight month study [abstract]. Neurobiol Aging. 1996;17(suppl 4):652.
11. Schneider LS, Pollock VE, Lyness SA. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc. 1990;38:553-563.
12. Billig N, Cohen-Mansfield J, Lipson S. Pharmacologic treatment of agitation in a nursing home: one possible role of sub-typing. J Am Geriatr Soc. 1991:39:1002-1005.
13. Cohen-Mansfield J, Lipson S, Gruber-Baldini AL, Farley J, Woosley R. Longitudinal prescribing patterns of psychotropic drugs in nursing home residents. Exp Clin Psychopharmacol. 1996;4:224-233.
14. Werner P, Cohen-Mansfield J, Farley J, Segal G, Lipson S. Effects of removal of physical restraints on psychotropic medication in the nursing home. J Geriatr Drug Ther. 1994;8:59-71.
15. Werner P, Cohen-Mansfield J, Koroknay V, Braun J. Restraints: impact on staff attitudes. J Gerontol Nurs. 1994;20:19-24.
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
17. Cohen-Mansfield J, Werner P, Marx MS. The impact of infection on agitation: three case studies in the nursing home. Am J Alzheimer Care Related Disord Res. 1994;July/August:30-34.
18. Reisberg B, Schneck MK, Ferris SH, Schwartz GE, de Leon MJ. The Brief Cognitive Rating Scale (BCRS): findings in primary degenerative dementia (PDD). Psychopharmacol Bull. 1983;19:47-50.
19. Beller SA, Overall JE. The brief psychiatric rating scale in geropsychiatric research, II: representative profile patterns. J Gerontol. 1984:39:194-200.
20. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962; 10:799-812.
21. Hedlund JL, Vieweg BW. The Brief Psychiatric Rating Scale (BPRS): a comprehensive review. J Operational Psychiatry. 1980;11:48-65.
22. Overall JE, Beller SA. The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research, I: factor structure on an inpatient unit. J Gerontol. 1984;39:187-193.
23. Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J Gerontol Med Sci. 1989;4:M77-M84.
24. Folstein MF, Folstein SE, McHugh PR. "Mini-menial state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
25. Cohen-Mansfield J, Marx MS. The relationship between sleep disturbances and agitation in a nursing home. J Aging Health. 1990;2:153-165.
26. Schooler NR. Evaluation of drug-related movement disorders in the aged. Psychopharmacol Bull. 1988;24:603-607.
27. Cohen-Mansfield J, Marx MS, Rosenthal AS. Dementia and agitation in nursing home residents: how are they related? Psychol Aging. 1990;5:3-8.
28. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1960;9:179-186.
29. Eutis NN, Patten SK. The effectiveness of long-term care. In: Mangen DJ, Peterson WA, eds. Health, Program Evaluation, and Demography. Vol. 3. Minneapolis: University of Minnesota Press; 1984:217-316.
30. Schneider L, Pollock V, Lyness S. A meta analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc. 1990;38:553-563.
31. Treves T, Verchovsky R, Klimovitski S, Korczyn A. Recruitment rate to drug trials for dementia of the Alzheimer type. Abstract presented at: Eighth Congress of the International Psychogeriatric Association; August 17-22,1997; Jerusalem, Israel.